Influence of altered cyclic 3',5'-adenosine monophosphate phosphodiesterase activity on systemic hemodynamics
Scholz, P.M.; Jolley, W.B.; Novinson, T.C.; Kaiser, J.E.; Smith, L.L.
Surgical Forum 23(0): 189-191
1972
ISSN/ISBN: 0071-8041 PMID: 4366237 Document Number: 44361
Document emailed within 1 workday
Related Documents
Scher, N.S.; Quagliata, F.; Malathi, V.G.; Faig, D.; Melton, R.A.; Silber, R. 1976: Cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in normal and chronic lymphocytic leukemia lymphocytes Cancer Research 36(11 Part 1): 3958-3962Yamasaki, Y.; Fujiwara, M.; Toda, N. 1974: Effects of intracellularly applied cyclic 3',5'-adenosine monophosphate and dibutyryl cyclic 3',5'-adenosine monophosphate on the electrical activity of sinoatrial nodal cells of the rabbit Journal of Pharmacology and Experimental Therapeutics 190(1): 15-20
Hickie, R.A.; Walker, C.M.; Datta, A. 1975: Increased activity of low-Km cyclic adenosine 3':5'-monophosphate phosphodiesterase in plasma membranes of Morris hepatoma 5123tc (h) Cancer Research 35(3): 601-605
Pastan, I.H.; Willingham, M.; de Crombrugghe, B.; Gottesman, M.M. 1982: Aging and cancer: cyclic 3', 5'-adenosine monophosphate and altered gene activity National Cancer Institute Monograph 60: 7-15
Mufson, R.A.; Simsiman, R.C.; Boutwell, R.K. 1979: Increased cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in the epidermis of phorbol ester-treated mouse skin and in papillomas Cancer Research 39(6 Part 1): 2036-2040
Kozhemiakin, L.A.; Korostovtsev, D.S.; Koroleva, T.R. 1978: Antihypoxic effect of analogs of cyclic adenosine monophosphate, phosphodiesterase inhibitors Farmakologiia i Toksikologiia 41(6): 711-714
Gräfe, U.; Römer, W. 1991: 2-Aza-anthraquinones as inhibitors of the Ca(2+)- and calmodulin-dependent cyclic adenosine 3',5'-monophosphate phosphodiesterase Die Pharmazie 46(4): 297-298
Kofinas, A.D.; Rose, J.C.; Koritnik, D.R.; Meis, P.J. 1990: Progesterone and estradiol concentrations in nonpregnant and pregnant human myometrium. Effect of progesterone and estradiol on cyclic adenosine monophosphate-phosphodiesterase activity Journal of Reproductive Medicine 35(11): 1045-1050
Zahavi, M.; Zahavi, J.; Kakkar, V.V. 1984: Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation Thrombosis and Haemostasis 52(2): 205-209
Malamud, D.; Irwin, D. 1978: Altered cyclic adenosine 3':5'-monophosphate metabolism and enzymatic profiles of a transplantable murine submaxillary gland carcinoma (myoepithelioma) Cancer Research 38(9): 2945-2949
Nedvídková, J.; Felt, V. 1984: Plasma levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) in patients with thyropathies Casopis Lekaru Ceskych 123(27): 835-837
Polson, J.B.; Krzanowski, J.J.; Szentivanyi, A. 1974: Histamine induced changes in pulmonary guanosine-3',5'-cyclic monophosphate (cGMP) and adenosine-3',5'-cyclic monophosphate (cAMP) levels in mice following sensitization by Bordetella pertussis and/or propranolol Research Communications in Chemical Pathology and Pharmacology 9(2): 243-251
Goldring, S.R.; Amento, E.P.; Roelke, M.S.; Krane, S.M. 1986: The adenosine 3':5'-cyclic monophosphate response to prostaglandin E2 is altered in U937 cells in association with maturational events induced by activated T lymphocytes and 1,25-dihydroxyvitamin D3 Journal of Immunology 136(9): 3461-3466
Felt, V.; Nedvídková, J.; Hynie, S.; Mosinger, B.; Vavrínková, H. 1979: Influence of thyrotoxicosis on adrenergic receptors, cyclic adenosine monophosphate, glycogen and some enzymes in the heart muscle Czechoslovak Medicine 2(1-2): 11-22
Weth, G. 1983: The influence of piracetam on the cyclic adenosine monophosphate (cAMP) concentration in the brain and colon of guinea pigs Arzneimittel-Forschung 33(6): 812-814
Turakulov, I.K.; Atakhanova, B.A.; Kadyrova, D.A. 1975: Stimulation of the protein synthesizing capacity of thyroid gland polyribosomes in vitro under the influence of cyclic adenosine-3', 5'-monophosphate Problemy Endokrinologii 21(2): 82-85
Nikulin, A.A. 1978: Effect of cyclic adenosine monophosphate and guanosine monophosphate on the aggregation and nucleotide metabolism of the blood platelets Farmakologiia i Toksikologiia 41(2): 177-182
Shafie, S.M.; Cho-Chung, Y.S.; Gullino, P.M. 1979: Cyclic adenosine 3':5'-monophosphate and protein kinase activity in insulin-dependent and -independent mammary tumors Cancer Research 39(7 Part 1): 2501-2504
Viggiano, M.; Faletti, A.; Gimeno, M.A.; Gimeno, A.L. 1988: Influence of estrogens on in vivo and in vitro rat uterine motility. Relationships with histamine, cimetidine and tissue levels of 3',5' cyclic adenosine monophosphate Methods and Findings in Experimental and Clinical Pharmacology 10(4): 247-252
Pepe, S.; Tortora, G.; Noguchi, P.D.; Marti, G.E.; Washington, G.C.; Cho-Chung, Y.S. 1991: Effects of 8-chloroadenosine 3',5'-monophosphate and N6-benzyl-cyclic adenosine 5'-monophosphate on cell cycle kinetics of HL-60 leukemia cells Cancer Research 51(23 Part 1): 6263-6267